new_0222_0465|PRAX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0465|PRAX|1|Praxis Precision Medicines Inc Total Current Assets (Quarterly) (USD)|Praxis Precision Medicines Inc Cash and Short Term Investments (Quarterly) (USD)|Praxis Precision Medicines Inc Inventories (Quarterly) (USD)|Praxis Precision Medicines Inc Net PP&E (Quarterly) (USD)|Praxis Precision Medicines Inc Goodwill and Intangibles (Quarterly) (USD)|Praxis Precision Medicines Inc Total Liabilities (Quarterly) (USD)|Praxis Precision Medicines Inc Total Current Liabilities (Quarterly) (USD)|Praxis Precision Medicines Inc Total Long Term Liabilities (Quarterly) (USD)|Praxis Precision Medicines Inc Total Deposits (Quarterly) (USD)|Praxis Precision Medicines Inc Book Value (Quarterly) (USD)|Praxis Precision Medicines Inc Retained Earnings (Quarterly) (USD)|Praxis Precision Medicines Inc Treasury Stock (Quarterly) (USD)|Praxis Precision Medicines Inc EV to Revenues|Praxis Precision Medicines Inc EV to Earnings|Praxis Precision Medicines Inc EV to Free Cash Flow|Praxis Precision Medicines Inc EV to Assets (Quarterly)|Praxis Precision Medicines Inc PS Ratio|Praxis Precision Medicines Inc PE Ratio|Praxis Precision Medicines Inc Price to Book Value|Praxis Precision Medicines Inc PEG Ratio|Praxis Precision Medicines Inc Debt to Equity Ratio|Praxis Precision Medicines Inc Dividend Yield|Praxis Precision Medicines Inc Shareholder Yield (TTM)|Praxis Precision Medicines Inc Percent of Shares Outstanding Short|Praxis Precision Medicines Inc Total Receivables (Quarterly) (USD)|Praxis Precision Medicines Inc Total Payables (Quarterly) (USD)|Praxis Precision Medicines Inc Total Capital Stock (Quarterly) (USD)|Praxis Precision Medicines Inc Return on Invested Capital|Praxis Precision Medicines Inc Quality Ratio Score|Praxis Precision Medicines Inc Momentum Score|Praxis Precision Medicines Inc Beta (1Y)|Praxis Precision Medicines Inc Sustainable Growth Rate (TTM)|Praxis Precision Medicines Inc Institutional Investor Ownership Percentage|Praxis Precision Medicines Inc Average Diluted Shares Outstanding (Quarterly)|Praxis Precision Medicines Inc Total Employees (Annual)|Praxis Precision Medicines Inc EPS Diluted (Quarterly) (USD)|Praxis Precision Medicines Inc SG&A Expense (Quarterly) (USD)|Praxis Precision Medicines Inc Shares Outstanding|Praxis Precision Medicines Inc Repurchase of Capital Stock (Quarterly) (USD)|Praxis Precision Medicines Inc Ordinary Shares Number (Quarterly)|Praxis Precision Medicines Inc Payout Ratio|Praxis Precision Medicines Inc Quick Ratio (Quarterly)|Praxis Precision Medicines Inc Normalized Diluted EPS (Quarterly) (USD)|Praxis Precision Medicines Inc Stock Buybacks (Quarterly) (USD)|Praxis Precision Medicines Inc Effective Tax Rate (TTM)|Praxis Precision Medicines Inc Return on Equity|Praxis Precision Medicines Inc Net Income (TTM) (USD)|Praxis Precision Medicines Inc Revenue (TTM) (USD)|Praxis Precision Medicines Inc Dividend Per Share (Quarterly) (USD)|Praxis Precision Medicines Inc Revenue (Quarterly) (USD)|Praxis Precision Medicines Inc Gross Profit (Quarterly) (USD)|Praxis Precision Medicines Inc Pre-Tax Income (Quarterly) (USD)|Praxis Precision Medicines Inc Net Income (Quarterly) (USD)|Praxis Precision Medicines Inc Net Interest Income (Quarterly) (USD)|Praxis Precision Medicines Inc Price (USD)|Praxis Precision Medicines Inc Total Return Price (USD)|Praxis Precision Medicines Inc Enterprise Value (USD)|Praxis Precision Medicines Inc 30-Day Average Daily Volume|Praxis Precision Medicines Inc 1 Year Price Returns (Daily)|Praxis Precision Medicines Inc Short Interest|Praxis Precision Medicines Inc PE Ratio (Forward)|Praxis Precision Medicines Inc PE Ratio (Forward 1y)|Praxis Precision Medicines Inc PS Ratio (Forward)|Praxis Precision Medicines Inc PS Ratio (Forward 1y)|Praxis Precision Medicines Inc Quarterly EPS Estimates (USD)|Praxis Precision Medicines Inc Quarterly Revenue Estimates (USD)|Praxis Precision Medicines Inc Quarterly EPS Surprise|Praxis Precision Medicines Inc Quarterly Revenue Surprise|Praxis Precision Medicines Inc Quarterly Actual EPS (USD)|Praxis Precision Medicines Inc Quarterly Actual Revenue (USD)|Praxis Precision Medicines Inc Revenue Estimates for Current Fiscal Year (USD)|Praxis Precision Medicines Inc Revenue Estimates for Next Fiscal Year (USD)|Praxis Precision Medicines Inc Price Target (USD)|Praxis Precision Medicines Inc Consensus Recommendation|Praxis Precision Medicines Inc Price Target Num Estimates|Praxis Precision Medicines Inc EPS Estimates for Current Fiscal Year (USD)|Praxis Precision Medicines Inc EPS Estimates for Next Fiscal Year (USD)|Praxis Precision Medicines Inc Research and Development Expense (Quarterly) (USD)|Praxis Precision Medicines Inc Reconciled Depreciation (Quarterly) (USD)|Praxis Precision Medicines Inc Non-Operating Interest Expense (Quarterly) (USD)|Praxis Precision Medicines Inc Land and Improvements (Quarterly) (USD)|Praxis Precision Medicines Inc Buildings and Improvements (Quarterly) (USD)|Praxis Precision Medicines Inc Other Properties (Quarterly) (USD)|Praxis Precision Medicines Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0465|PRAX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0465|PRAX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0465|PRAX|5|106.5|106.5||106.5||106.5|106.5|106.5||106.5|106.5||||1.44755244755||||1.44755244755|||1.44970414201||15.2666666667||106.5|106.5|||31|30.6666666667|||91.375|92|91.375|91.375|32.0833333333|91.3333333333|106.5|||91.375|91.4|91.4||91.4|||||91.375|91.375|91.3333333333|1.44970414201|1.44970414201|1.44970414201|1.4498381877|1.43023255814|15.2666666667|||||91.4|91.3333333333||||91.25|25.7222222222|32.8571428571|22.0476190476|11.8717948718|22.0476190476|56|56|91.375|91.375|||106.5|106.5|122||
new_0222_0465|PRAX|6|6|6||6||6|6|6||6|6||||286||||286|||338||30||6|6|||2|3|||8|1|8|8|12|6|6|||8|5|5||5|||||8|8|6|338|338|338|309|86|30|||||5|9||||4|18|14|21|39|21|2|2|8|8|||6|6|3||
new_0222_0465|PRAX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0465|PRAX|201909||||||||||||||||||||||||||||||||||17.1773||-0.6912|1.308||||||-0.6174|||||||||-10.606|-10.606|0.048||||||||||||||||||||||||9.346|0.01|||||||
new_0222_0465|PRAX|201912|45.496|44.815||1.578||128.702|6.818|121.884||-81.008|-81.009|||||||||||||||2.667|0.001|||||||17.1773||-0.5302|1.795|||36.7497|||-0.4301|||||||||-7.472|-7.388|0.022||||||||||||||||||||||||5.699|0.01|||1.45|0.048|0.118||
new_0222_0465|PRAX|202003||||||||||||||||||||||||||||||||||17.1773||-0.5764|1.601||-30||||-0.4849|||||||||-8.341|-8.33|0.128||||||||||||||||||||||||6.868|0.01|||||||
new_0222_0465|PRAX|202006|20.44|19.748||1.217||8.547|8.157|0.39||14.106|-104.085|||||||||||||||3.688|0.002|||||||17.1773||-0.7922|2.52|||36.7497|||-0.6734||0.2422||-37.892|||||-11.565|-11.568|||||||||||||||||||||||||9.05|0.01|||1.109|0.108|||
new_0222_0465|PRAX|202009|115.851|114.772||1.031||242.811|10.384|232.427||-123.263|-123.264|||||||||||||1.4783||3.452|0.001||||||11.0074|36.7497|51|-0.5485|3.431|36.7497||36.7497|||-0.4413||0.211||-43.502|||||-16.216|-16.216||35|35|1171.4675|252141.2||543282|||||||||||||53.3333|1.25|3|||12.786|0.01|||0.933|0.098||41.46|
new_0222_0465|PRAX|202012|302.326|296.608||0.836||15.72|15.72|||287.457|-149.554||||-34.3752||||7.3247|||||5.4009||4.088|0.004|||||||38.2685|67|-0.6966|9.44|38.2685||38.2685|||-0.6966|-200.886|0.0129||-61.82|||||-25.706|-25.706||55.02|55.02|1808.9249|339198.4||2066837|||||||||||||62|1.25|3|||16.272|0.02|||0.754|0.048|0.122|50.89|43.5
new_0222_0465|PRAX|202103|278.564|270.811||0.68||13.738|13.738|||265.515|-176.927||||-14.2515||||4.7652|||||5.2409||5.774|0.004|||||||38.4707||-0.71|9.49|38.621||38.621|||-0.71||-0.0037||-80.863|||||-27.373|-27.373|0.046|32.76|32.76|994.413|173084.6||2024107|||||||||||||66|1.25|3|||17.929|0.023|||0.571|0.109||30.66|19.59
new_0222_0465|PRAX|202106|348.433|339.184||4.582||19.739|15.78|3.959||333.772|-213.328||||-5.3181||||2.4478|||||2.8184||7.401|0.005|||||||41.5698||-0.88|10.805|44.6932||44.6932|||-0.88|-98.576|||-105.696|||||-36.401|-36.401||18.28|18.28|477.8077|496670.2||1259630|||||||||||||65|1.2|4|-3.53|-4.33|25.678|0.027|||4.4|0.182||15.6|19.87
new_0222_0465|PRAX|202109|319.339|314.37||4.653||28.486|24.754|3.732||295.922|-258.033||||-5.1407||||2.7982|||||3.6249||7.544|0.005|||2|2.1563|||44.7149||-1|11.634|44.7841||44.7841|||-1|0.096|-0.0037||-134.185|||||-44.7|-44.705||18.49|18.49|513.688|313788.9667|-39.1457|1623384|||||-0.93||-7.5269||-1||||46|1.1667|3|-3.72|-4.42|33.139|0.039|||4.028|0.625||20.8|17.11
new_0222_0465|PRAX|202112|||||||||||||||-5.6972||||2.9861|||||4.0566||||||2|1.8515||||||||||||||||||||||||19.7|19.7|569.2893|354054.5333|-64.1948|1819641|||||-1.07||||||||47.074|1.3333|5|-3.695|-4.44||||||||14.86|12.73
new_0222_0465|PRAX|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.1|||||||||||||||||||||
new_0222_0465|PRAX|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.14|||||||||||||||||||||
new_0222_0465|PRAX|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.16|||||||||||||||||||||
new_0222_0465|PRAX|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.06|||||||||||||||||||||